Unveiling 26 Analyst Insights On Sarepta Therapeutics
Unveiling 26 Analyst Insights On Sarepta Therapeutics
揭示了26个关于sarepta therapeutics的分析师见解
The perception of Sarepta Therapeutics by financial experts is analyzed through...Ratings for Sarepta Therapeutics (NASDAQ:SRPT) were provided by 26 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去三个月中，26位分析师对Sarepta Therapeutics (纳斯达克股票代码：SRPT)进行了评级，展示了看好和看淡两种观点的混合态度。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
总结他们最近的评估，下表展示了过去30天内不断变化的情绪，并将其与之前的几个月进行了比较。
Analysts have set 12-month price targets for Sarepta Therapeutics, revealing an average target of $188.31, a high estimate of $235.00, and a low estimate of $128.00. This current average reflects an increase of 7.65% from the previous average price target of $174.92.
Analysts have set 12-month price targets for Sarepta Therapeutics, revealing an average target of $188.31, a high estimate of $235.00, and a low estimate of $128.00. This current average reflects an increase of 7.65% from the previous average price target of $174.92.
Deciphering Analyst Ratings: An In-Depth Analysis
分析师评级解读：深入分析
The perception of Sarepta Therapeutics by financial experts is analyzed through...
通过最近的分析师行动，...
登录免费看全文
登录/注册
资讯热榜
更新时间